Do Artemisia annua L. compounds have SARS-CoV-2 antiviral potential?

Caused by SARS-CoV-2, the ongoing COVID-19 pandemic has led to over 121.2 million cases and over 2.6 million deaths worldwide. An interesting new study examines the potential antiviral activity of compounds present in the plant Artemisia annua L.

IJMS, Free Full-Text

Small molecules in the treatment of COVID-19

Profiling some plant-based immunomodulatory bioactive compounds for COVID-19 prophylaxis and treatment based on Indian traditional medicine, Book

Network pharmacology-based predictions of active components and pharmacological mechanisms of Artemisia annua L. for the treatment of the novel Corona virus disease 2019 (COVID-19), BMC Complementary Medicine and Therapies

Artemisia annua L. hot-water extracts show potent activity in vitro against Covid-19 variants including delta - ScienceDirect

Artemisia annua L. extracts inhibit the in vitro replication of SARS-CoV-2 and two of its variants - ScienceDirect

Small molecules in the treatment of COVID-19

A phylogenetic perspective of antiviral species of the genus Artemisia (Asteraceae-Anthemideae): A proposal of anti SARS-CoV-2 (COVID-19) candidate taxa - ScienceDirect

IJMS, Free Full-Text

Antibiotics, Free Full-Text

IJMS, Free Full-Text

Antiviral, virucidal and antioxidant properties of Artemisia annua against SARS-CoV-2 - ScienceDirect

In vitro efficacy of artemisinin-based treatments against SARS-CoV-2

Artemisia plant extracts show potential anti-SARS-CoV-2 activity in vitro